Cornerstone Therapeutics Inc. (NASDAQ:CRTX)

CAPS Rating: 4 out of 5

A biopharmaceutical company focused on the development and commercialization of products designed to treat respiratory, inflammatory and critical care diseases linked to the body's inflammatory response.

Recs

0
Player Avatar bobsweet (< 20) Submitted: 3/18/2010 11:46:49 PM : Outperform Start Price: $5.60 CRTX Score: -22.94

If you really look indepth into this company then you would know it is poised to explode. Great forward P/E, P/S, P/Book while holding alot of cash with very little debt. 72.5% insider owned while still trading under 200M volume... Tom Gardner knows it and so should you. JUMP IN NOW!

Featured Broker Partners


Advertisement